Jacqueline N Williams

Title: Jacqueline N. Williams: Innovator in Glutaminase Inhibitors

Introduction

Jacqueline N. Williams is a prominent inventor based in West Lafayette, IN (US). She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of glutaminase inhibitors. With a total of 2 patents, her work is paving the way for innovative treatments in cancer and other diseases.

Latest Patents

Williams' latest patents focus on crystalline forms of glutaminase inhibitors. The first patent relates to crystalline salts of a compound with a specific structure, detailing methods for their preparation and related pharmaceutical compositions. This invention also encompasses methods for treating or preventing cancer and various immunological or neurological diseases through the administration of these crystalline salts. The second patent similarly addresses crystalline salts of a heterocyclic compound, including methods of preparation and related pharmaceutical preparations, along with treatment methods utilizing these crystalline salts.

Career Highlights

Jacqueline N. Williams is currently associated with Calithera Biosciences, Inc., where she continues to advance her research and innovations. Her work is instrumental in developing new therapeutic options that could significantly impact patient care.

Collaborations

Williams collaborates with notable colleagues, including Timothy Friend Stanton and James J. Springer, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Jacqueline N. Williams stands out as a key figure in the field of pharmaceutical innovation, particularly with her work on glutaminase inhibitors. Her contributions are vital for the advancement of treatments for serious health conditions.